• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌抗原125作为肝硬化患者腹水的标志物。

Cancer Antigen-125 as a marker of ascites in patients with liver cirrhosis.

作者信息

Qureshi Muhammad Omar, Dar Faisal Saud, Khokhar Nasir

机构信息

Department of Gastroenterology, Shifa International Hospital, Islamabad.

出版信息

J Coll Physicians Surg Pak. 2014 Apr;24(4):232-5.

PMID:24709233
Abstract

OBJECTIVE

To evaluate the correlation between Cancer Antigen-25 (CA-125) levels with the amount of ascites in patients with liver cirrhosis.

STUDY DESIGN

Observational, analytical study.

PLACE AND DURATION OF STUDY

Shifa International Hospital, Islamabad, from March 2012 to February 2013.

METHODOLOGY

A total of 130 patients with liver cirrhosis (with and without ascites) had serum CA-125 levels measured. The amount of ascites was classified according to physical examination and ultrasound (USG) findings. CA-125 levels were compared and correlated with amount of ascites.

RESULTS

Majority of patients (57%) had hepatitis C virus and 60% were in class Child Pugh C. There was moderate correlation between amount of ascites and CA-125 levels (r = 0.642, p < 0.001) with significant raised levels of CA-125 in patients with ascites (p < 0.001).

CONCLUSION

There was a moderate correlation between CA-125 levels and presence and amount of ascites.

摘要

目的

评估肝硬化患者癌抗原25(CA - 125)水平与腹水量之间的相关性。

研究设计

观察性分析研究。

研究地点及时间

2012年3月至2013年2月,伊斯兰堡的希法国际医院。

方法

共对130例肝硬化患者(有腹水和无腹水)进行血清CA - 125水平检测。根据体格检查和超声(USG)检查结果对腹水量进行分类。比较CA - 125水平并与腹水量进行相关性分析。

结果

大多数患者(57%)感染丙型肝炎病毒,60%为Child - Pugh C级。腹水量与CA - 125水平之间存在中度相关性(r = 0.642,p < 0.001),腹水患者的CA - 125水平显著升高(p < 0.001)。

结论

CA - 125水平与腹水的存在及腹水量之间存在中度相关性。

相似文献

1
Cancer Antigen-125 as a marker of ascites in patients with liver cirrhosis.癌抗原125作为肝硬化患者腹水的标志物。
J Coll Physicians Surg Pak. 2014 Apr;24(4):232-5.
2
Cancer antigen 125: a sensitive marker of ascites in patients with liver cirrhosis.癌抗原125:肝硬化患者腹水的敏感标志物。
Am J Gastroenterol. 1999 Jun;94(6):1613-8. doi: 10.1111/j.1572-0241.1999.01152.x.
3
Elevation of serum and ascites cancer antigen 125 levels in patients with liver cirrhosis.
J Gastroenterol Hepatol. 2003 Nov;18(11):1315-6. doi: 10.1046/j.1440-1746.2003.03180.x.
4
[Clinical significance of serum CA 125 in patients with chronic liver diseases].
Korean J Gastroenterol. 2003 Nov;42(5):409-14.
5
Cancer antigen-125 and ICAM-1 are together responsible for ascites in liver cirrhosis.癌抗原125和细胞间黏附分子-1共同导致肝硬化腹水。
Clin Lab. 2014;60(4):653-8. doi: 10.7754/clin.lab.2013.130403.
6
Cancer antigen 125 levels in patients with ascites.腹水患者的癌抗原125水平
Turk J Gastroenterol. 2003 Dec;14(4):257-61.
7
[Cancer antigen 125 as a marker of ascites in patients with liver cirrhosis].[癌抗原125作为肝硬化患者腹水的标志物]
Pol Merkur Lekarski. 2004;17 Suppl 1:149-52.
8
Evaluation of relationship between CA-125 levels and ascites in patients with liver cirrhosis.肝硬化患者CA-125水平与腹水关系的评估
J Coll Physicians Surg Pak. 2014 Nov;24(11):873.
9
[Evaluation on clinical value of serum CA-125 level in hepatitis cirrhosis].血清CA-125水平在肝硬化中的临床价值评估
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2010 Oct;24(5):334-6.
10
Serum, pleural effusion, and ascites CA-125 levels in ovarian cancer and nonovarian benign and malignant diseases: a comparative study.卵巢癌及非卵巢良恶性疾病患者血清、胸腔积液和腹水CA - 125水平的比较研究
Gynecol Oncol. 2002 Apr;85(1):108-13. doi: 10.1006/gyno.2001.6575.

引用本文的文献

1
CA125 as a Potential Biomarker in Non-Malignant Serous Effusions: Diagnostic and Prognostic Considerations.CA125作为非恶性浆液性积液中的潜在生物标志物:诊断和预后考量
J Clin Med. 2025 Jun 11;14(12):4152. doi: 10.3390/jcm14124152.
2
Establishment and validation of a predictive model of recurrence in primary hepatocellular carcinoma after resection.原发性肝细胞癌切除术后复发预测模型的建立与验证
J Gastrointest Oncol. 2023 Feb 28;14(1):278-286. doi: 10.21037/jgo-22-1303. Epub 2023 Feb 15.
3
Elevated Preoperative Serum CA125 Predicts Larger Tumor Diameter in Patients with Hepatocellular Carcinoma and Low AFP Levels.
术前血清 CA125 水平升高可预测 AFP 水平低的肝细胞癌患者肿瘤直径更大。
Biomed Res Int. 2019 Sep 29;2019:6959637. doi: 10.1155/2019/6959637. eCollection 2019.
4
Mucins: the Old, the New and the Promising Factors in Hepatobiliary Carcinogenesis.黏蛋白:在肝胆癌发生中的“旧将”、“新丁”与潜力因子。
Int J Mol Sci. 2019 Mar 14;20(6):1288. doi: 10.3390/ijms20061288.
5
Serum Tumor Marker Carbohydrate Antigen 125 Levels and Carotid Atherosclerosis in Patients with Coronary Artery Disease.冠心病患者血清肿瘤标志物糖类抗原125水平与颈动脉粥样硬化
Open Med (Wars). 2018 Dec 24;13:534-538. doi: 10.1515/med-2018-0078. eCollection 2018.
6
CA-125 Significance in Cirrhosis and Correlation with Disease Severity and Portal Hypertension: A Retrospective Study.CA-125在肝硬化中的意义及其与疾病严重程度和门静脉高压的相关性:一项回顾性研究。
J Clin Transl Hepatol. 2018 Sep 28;6(3):241-246. doi: 10.14218/JCTH.2017.00070. Epub 2018 Jul 2.